Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer.
Yuejiao ZhongQingyu FanZhaofei ZhouYajing WangKang HeJian-Wei LuPublished in: Cancer management and research (2020)
Plasma cfDNA concentration was significantly increased in patients with gastric cancer, and its diagnostic efficacy was superior to that of traditional tumor markers. It can be used as a tumor biomarker to monitor the efficacy of chemotherapy for gastric cancer.
Keyphrases